236 related articles for article (PubMed ID: 30764654)
1. Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design.
Chhatriwalla AK; Decker C; Gialde E; Catley D; Goggin K; Jaschke K; Jones P; deBronkart D; Sun T; Spertus JA
Circ Cardiovasc Qual Outcomes; 2019 Feb; 12(2):e005139. PubMed ID: 30764654
[TBL] [Abstract][Full Text] [Related]
2. Beyond restenosis: Patients' preference for drug eluting or bare metal stents.
Qintar M; Chhatriwalla AK; Arnold SV; Tang F; Buchanan DM; Shafiq A; Pokharel Y; deBronkart D; Ashraf JM; Spertus JA
Catheter Cardiovasc Interv; 2017 Sep; 90(3):357-363. PubMed ID: 28168845
[TBL] [Abstract][Full Text] [Related]
3. Predictors and variability of drug-eluting vs bare-metal stent selection in contemporary percutaneous coronary intervention: Insights from the PRISM study.
Shafiq A; Gosch K; Amin AP; Ting HH; Spertus JA; Salisbury AC
Clin Cardiol; 2017 Aug; 40(8):521-527. PubMed ID: 28300284
[TBL] [Abstract][Full Text] [Related]
4. Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?
Costa F; Brugaletta S; Pernigotti A; Flores-Ulmanzor E; Ortega-Paz L; Cequier A; Iniguez A; Serra A; Jiménez-Quevedo P; Mainar V; Campo G; Tespili M; den Heijer P; Bethencourt A; Vazquez N; van Es GA; Backx B; Valgimigli M; Serruys P; Sabaté M
Circ Cardiovasc Interv; 2019 Sep; 12(9):e007705. PubMed ID: 31451013
[TBL] [Abstract][Full Text] [Related]
5. PREPARED Study: A Study of Shared Decision-Making for Coronary Artery Disease.
Doll JA; Jones WS; Lokhnygina Y; Culpepper S; Parks RL; Calhoun C; Au DH; Patel MR
Circ Cardiovasc Qual Outcomes; 2019 Feb; 12(2):e005244. PubMed ID: 30764651
[TBL] [Abstract][Full Text] [Related]
6. Understanding operator stent choice in the catheterization laboratory using a pre-procedure survey: Opportunities for quality improvement.
Chung MJ; Hansen JD; Schulteis RD; Boggan JC; Jones WS; Povsic TJ; Roberts S; Krucoff MW; Rao SV
Cardiovasc Revasc Med; 2017 Dec; 18(8):588-591. PubMed ID: 28529095
[TBL] [Abstract][Full Text] [Related]
7. Comparison of drug-eluting and bare-metal stents in patients with diabetes undergoing primary percutaneous coronary intervention: what is the evidence?
Gollop ND; Henderson DB; Flather MD
Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):112-6. PubMed ID: 24144807
[TBL] [Abstract][Full Text] [Related]
8. Re-Evaluating the Safety of Drug-Eluting Stents in Cancer Patients.
Ganatra S; Sharma A; Levy MS
JACC Cardiovasc Interv; 2017 Nov; 10(22):2334-2337. PubMed ID: 29169502
[TBL] [Abstract][Full Text] [Related]
9. Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial.
Crimi G; Leonardi S; Costa F; Adamo M; Ariotti S; Valgimigli M
Int J Cardiol; 2016 Jun; 212():110-7. PubMed ID: 27038714
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
[TBL] [Abstract][Full Text] [Related]
11. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
[TBL] [Abstract][Full Text] [Related]
12. One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients.
Kandzari DE; Kirtane AJ; Windecker S; Latib A; Kedhi E; Mehran R; Price MJ; Abizaid A; Simon DI; Worthley SG; Zaman A; Choi JW; Caputo R; Kanitkar M; McLaurin B; Potluri S; Smith T; Spriggs D; Tolleson T; Nazif T; Parke M; Lee LC; Lung TH; Stone GW;
Circ Cardiovasc Interv; 2020 Nov; 13(11):e009565. PubMed ID: 33167705
[TBL] [Abstract][Full Text] [Related]
13. PCI Choice Decision Aid for Stable Coronary Artery Disease: A Randomized Trial.
Coylewright M; Dick S; Zmolek B; Askelin J; Hawkins E; Branda M; Inselman JW; Zeballos-Palacios C; Shah ND; Hess EP; LeBlanc A; Montori VM; Ting HH
Circ Cardiovasc Qual Outcomes; 2016 Nov; 9(6):767-776. PubMed ID: 27803090
[TBL] [Abstract][Full Text] [Related]
14. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
15. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
Yoshikawa Y; Shiomi H; Watanabe H; Natsuaki M; Kondo H; Tamura T; Nakagawa Y; Morimoto T; Kimura T
Circulation; 2018 Feb; 137(6):551-562. PubMed ID: 28982692
[TBL] [Abstract][Full Text] [Related]
16. Consensus Decision-Making for the Management of Antiplatelet Therapy before Non-Cardiac Surgery in Patients Who Underwent Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents: A Cohort Study.
Kim C; Kim JS; Kim H; Ahn SG; Cho S; Lee OH; Park JK; Shin S; Moon JY; Won H; Suh Y; Cho JR; Cho YH; Oh SJ; Lee BK; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
J Am Heart Assoc; 2021 Apr; 10(8):e020079. PubMed ID: 33843258
[TBL] [Abstract][Full Text] [Related]
17. Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial.
Ariotti S; Adamo M; Costa F; Patialiakas A; Briguori C; Thury A; Colangelo S; Campo G; Tebaldi M; Ungi I; Tondi S; Roffi M; Menozzi A; de Cesare N; Garbo R; Meliga E; Testa L; Gabriel HM; Ferlini M; Vranckx P; Valgimigli M;
JACC Cardiovasc Interv; 2016 Mar; 9(5):426-36. PubMed ID: 26965932
[TBL] [Abstract][Full Text] [Related]
18. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
[TBL] [Abstract][Full Text] [Related]
19. Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement.
Stolker JM; Cohen DJ; Kennedy KF; Pencina MJ; Arnold SV; Kleiman NS; Spertus JA;
Cardiovasc Revasc Med; 2017; 18(3):169-176. PubMed ID: 28041858
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
